Genentech
ACTEMRA
Manufacturer:
Genentech
Name:
ACTEMRA
HCPCS Code Descriptor:
Injection, tocilizumab, 1 mg
Category:
J Code
HCPCS:
J3262
NDC(s):
50242-0135-01, 50242-0143-01, 50242-0138-01, 50242-0137-01, 50242-0136-01
Primary Type:
Immunology:Anti-TNF
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
ACTEMRA is an Immunology:Anti-TNF drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J3262 is aligned to the drug ACTEMRA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/11
HCPCS Effective Date:
1/1/11
HCPCS Short Description:
Tocilizumab injection
Billing and Coding Guide:
https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/ACTEMRA-Billing-Coding-for-IV.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation